Provided by Tiger Fintech (Singapore) Pte. Ltd.

OraSure

2.89
+0.08002.85%
Post-market: 2.920.0300+1.04%18:52 EDT
Volume:968.54K
Turnover:2.82M
Market Cap:216.17M
PE:-6.75
High:2.96
Open:2.88
Low:2.85
Close:2.81
Loading ...

OraSure Technologies Inc expected to post a loss of 6 cents a share - Earnings Preview

Reuters
·
22 Feb

OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th

GlobeNewswire
·
14 Feb

OraSure (OSUR) Upgraded to Strong Buy: What Does It Mean for the Stock?

Zacks
·
28 Jan

Should Value Investors Buy OraSure Technologies (OSUR) Stock?

Zacks
·
23 Jan

Bear of the Day: Baxter (BAX)

Zacks
·
22 Jan

New Strong Buy Stocks for January 16th

Zacks
·
16 Jan

OraSure to Present at the J.P Morgan Healthcare Conference

GlobeNewswire
·
08 Jan

Are Investors Undervaluing OraSure Technologies (OSUR) Right Now?

Zacks
·
07 Jan

OraSure Technologies Shares up 4% Premarket After Oraquick® Hiv Self-Test Approved for Use in Adolescents

THOMSON REUTERS
·
07 Jan

BRIEF-OraQuick HIV Self-Test Approved For Use In Adolescents

Reuters
·
07 Jan

OraSure’s OraQuick HIV Self-Test now approved for use in adolescents

TIPRANKS
·
07 Jan

Oraquick® Hiv Self-Test NOW Approved for Use in Adolescents

THOMSON REUTERS
·
07 Jan

OraQuick® HIV Self-Test Now Approved for Use in Adolescents

GlobeNewswire
·
07 Jan

OraSure price target lowered to $4 from $5 at Evercore ISI

TIPRANKS
·
02 Jan

OSUR Stock Rises Following the Acquisition of Sherlock Biosciences

Zacks
·
27 Dec 2024

OraSure Technologies Buys Sherlock Biosciences; Shares Rise After Hours

MT Newswires Live
·
20 Dec 2024

OraSure acquires Sherlock Biosciences, terms undisclosed

TIPRANKS
·
20 Dec 2024

BRIEF-Orasure Technologies Acquires Sherlock Biosciences

Reuters
·
20 Dec 2024

OraSure Technologies Acquires Sherlock Biosciences

THOMSON REUTERS
·
20 Dec 2024

OraSure Technologies Inc - Sherlock's Ct/Ng Self-Test Expected to Be Submitted to FDA by End of 2025

THOMSON REUTERS
·
20 Dec 2024